PARISER, D.; SUSSMAN, J.; MARTIN, B.; ACKERMAN, L.; KRAFFERT, C.; JARELL, A. Real-World Evidence Confirms Risk Stratification of the 31-GEP and i31-GEP in Prospectively Tested Patients with Stage I-III Cutaneous Melanoma . SKIN The Journal of Cutaneous Medicine, [S. l.], v. 8, n. 2, p. s386, 2024. DOI: 10.25251/skin.8.supp.386. Disponível em: https://dermsquared.com/skin/article/view/2596. Acesso em: 20 sep. 2024.